Preventing cardiovascular disease among Canadians: What are the potential benefits of treating hypertension or dyslipidemia?

This publication has 33 references indexed in Scilit:

• Impact of dyslipidemia associated with Highly Active Antiretroviral Therapy (HAART) on cardiovascular risk and life expectancy**The sponsor provided the principal investigator with the results of study AI 424-008 before the study's subsequent publication but did not participate in the data analysis presented in this report. A draft of the manuscript was submitted to the sponsor before submission with the understanding that the final manuscript remained under the complete control of the principal investigator.
  The American Journal of Cardiology, 2005
• Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis
  BMJ, 2003
• Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials
  BMJ, 2003
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group
  1997
• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• Population awareness and control of hypertension and hypercholesterolemia. The Atherosclerosis Risk in Communities study
  Archives of internal medicine (1960), 1995
• Hypertension in the elderly. Implications and generalizability of randomized trials
  JAMA, 1994
• Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study.
  Circulation, 1980
• EVALUATION OF DRUG TREATMENT IN MILD HYPERTENSION: VA‐NHLBI FEASIBILITY TRIAL*
  Annals of the New York Academy of Sciences, 1978